Trial Profile
A retrospective study evaluating the long term clinical outcomes with iloprost therapy in patients with critical limb ischaemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2017
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Chronic limb-threatening ischemia; Peripheral arterial disorders; Peripheral ischaemia
- Focus Therapeutic Use
- 30 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology